Atomi Financial Group’s Novo Nordisk NVO Stock Holding History

Atomi Financial Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Buy	33,152 +15,015	+83%	+$645K	0.04%	331
2026 Q1	$667K	Sell	18,137 -12,200	-40%	-$578K	0.02%	593
2025 Q4	$1.54M	Buy	30,337 +2,294	+8%	+$117K	0.05%	282
2025 Q3	$1.56M	Sell	28,043 -10,687	-28%	-$626K	0.05%	251
2025 Q2	$2.67M	Buy	38,730 +8,560	+28%	+$582K	0.1%	148
2025 Q1	$2.09M	Sell	30,170 -1,976	-6%	-$163K	0.1%	159
2024 Q4	$2.77M	Buy	32,146 +1,473	+5%	+$159K	0.14%	117
2024 Q3	$3.65M	Sell	30,673 -2,203	-7%	-$294K	0.23%	87
2024 Q2	$4.69M	Buy	32,876 +4,937	+18%	+$654K	0.35%	61
2024 Q1	$3.59M	Buy	27,939 +3,170	+13%	+$377K	0.33%	67
2023 Q4	$2.56M	Buy	24,769 +16,802	+211%	+$1.66M	0.35%	59
2023 Q3	$725K	Buy	+7,967	New	+$702K	0.24%	107

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Atomi Financial Group's NVO Position: Q2 2026 in Review

Atomi Financial Group increased its Novo Nordisk (NVO) stake by 83% in Q2 2026, buying an estimated $645K and bringing the position to 33,152 shares worth $1.59M. The position accounts for 0.04% of the portfolio, ranked #331.

Atomi Financial Group first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.69M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Atomi Financial Group held 33,152 shares of Novo Nordisk worth $1.59M as of Q2 2026.
Atomi Financial Group bought 15,015 Novo Nordisk shares in Q2 2026, an estimated $645K.
Novo Nordisk made up 0.04% of Atomi Financial Group's portfolio in Q2 2026, its #331 holding.
Atomi Financial Group first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
Atomi Financial Group's Novo Nordisk position peaked at $4.69M in Q2 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.